Frederic R Curtiss,Phillip Lettrich,Kathleen A Fairman
Frederic R Curtiss
An article on the front page of the Wall Street Journal on October 6, 2006, thrust into the public media the otherwise esoteric controversy concerning the use of average wholesale price (AWP) as the primary basis for reimbursements to pharm...
Budgetary impact of treatment with adjuvant imatinib for 1 year following surgical resection of Kit-positive localized gastrointestinal stromal tumors [0.03%]
KIT阳性局部胃肠道间质瘤手术切除后辅助使用伊马替尼一年的治疗预算影响分析
Jaime L Rubin,Douglas C A Taylor,Myrlene Sanon et al.
Jaime L Rubin et al.
Background: Imatinib mesylate, an orally administered kinase inhibitor that targets the Kit (CD117) protein, currently has 10 approved indications including treatment of chronic myelogenous leukemia and metastatic gastroi...
Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center [0.03%]
一项退伍军人医疗机构中胺碘酮与辛伐他汀联合治疗患者的安全部署计划的效果研究
Sahar Karimi,Augustus Hough,Cherylyn Beckey et al.
Sahar Karimi et al.
Background: The FDA revised the labels of amiodarone and simvastatin in 2002 to warn of increased risk of rhabdomyolysis, the most severe form of myopathy, when the 2 drugs are taken concomitantly in doses greater than 20...
Robert C Johnson
Robert C Johnson
Edmond S Weisbart
Edmond S Weisbart
Brian K Crownover
Brian K Crownover
Tough questions about the value of statin therapy for primary prevention: did JUPITER miss the moon? [0.03%]
他汀类药物治疗一级预防的疗效几何？JUPITER试验说明了什么？
Frederic R Curtiss,Kathleen A Fairman
Frederic R Curtiss
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis [0.03%]
两种新的生物制剂的药典评审：托珠单抗治疗类风湿性关节炎和乌司奴单抗治疗斑块型银屑病
Jeremy A Schafer,Nicole K Kjesbo,Patrick P Gleason
Jeremy A Schafer
Background: Two autoimmune biologics were recently approved by the FDA: ustekinumab in September 2009 for the treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic ther...
Development and delivery of a quality improvement program to reduce antipsychotic polytherapy [0.03%]
减少抗精神病药物多药治疗的质量改善项目的发展和实施
Jessica L Gören,Stuart E Beck,Barry J Mills et al.
Jessica L Gören et al.
Background: Although antipsychotic polytherapy is considered appropriate in limited circumstances (e.g., during a brief "cross-titration" period when switching medications), its increasing prevalence indicates use beyond ...
Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization [0.03%]
在医师-医院组织中增加通用药品代金券以补充药学学术推广项目对通用药物调配比率的影响
Vinay Bhargava,Mark E Greg,Mark C Shields
Vinay Bhargava
Background: Generic dispensing ratio (GDR) is an important measure of efficiency in pharmacy benefit management. A few studies have examined the effects of academic detailing or generic drug samples on GDR. On July 1, 200...